Pages that link to "Q27660498"
Jump to navigation
Jump to search
The following pages link to A Small-Molecule Inhibitor of BCL6 Kills DLBCL Cells In Vitro and In Vivo (Q27660498):
Displaying 50 items.
- The epigenetic basis of diffuse large B-cell lymphoma (Q26852288) (← links)
- Epigenetic regulation of fetal globin gene expression in adult erythroid cells (Q26864609) (← links)
- Computational methods in drug discovery (Q26997089) (← links)
- Beyond high-dose methotrexate and brain radiotherapy: novel targets and agents for primary CNS lymphoma (Q27013785) (← links)
- Current concepts in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (Q27025242) (← links)
- Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review (Q27304386) (← links)
- Structural Basis for Cul3 Protein Assembly with the BTB-Kelch Family of E3 Ubiquitin Ligases (Q27675990) (← links)
- The structure of the Bach2 POZ-domain dimer reveals an intersubunit disulfide bond (Q27676372) (← links)
- The ansamycin antibiotic, rifamycin SV, inhibits BCL6 transcriptional repression and forms a complex with the BCL6-BTB/POZ domain (Q27681982) (← links)
- Targeting transcription factor SALL4 in acute myeloid leukemia by interrupting its interaction with an epigenetic complex (Q28282573) (← links)
- Structure based discovery of small molecules to regulate the activity of human insulin degrading enzyme (Q28480725) (← links)
- EZH2 and BCL6 Cooperate to Assemble CBX8-BCOR Complex to Repress Bivalent Promoters, Mediate Germinal Center Formation and Lymphomagenesis (Q28771717) (← links)
- BCL6 modulation of acute lymphoblastic leukemia response to chemotherapy (Q28829626) (← links)
- Characterization of ERK docking domain inhibitors that induce apoptosis by targeting Rsk-1 and caspase-9. (Q33789572) (← links)
- The transcriptional modulator BCL6 as a molecular target for breast cancer therapy (Q34245186) (← links)
- Pathogenesis of human B cell lymphomas (Q34245261) (← links)
- Rhodanine as a scaffold in drug discovery: a critical review of its biological activities and mechanisms of target modulation. (Q34274409) (← links)
- MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphoma (Q34366539) (← links)
- Transcriptional repressors, corepressors and chromatin modifying enzymes in T cell development (Q34626885) (← links)
- KAP1 promotes proliferation and metastatic progression of breast cancer cells (Q34979737) (← links)
- BCL6 is a negative prognostic factor and exhibits pro-oncogenic activity in ovarian cancer (Q34991219) (← links)
- Computational ligand-based rational design: Role of conformational sampling and force fields in model development. (Q35069159) (← links)
- Novel therapeutics for aggressive non-Hodgkin's lymphoma (Q35111768) (← links)
- Suppression of human B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin involves altered regulation of B cell lymphoma-6. (Q35145901) (← links)
- BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia (Q35441406) (← links)
- Targeting multiple conformations leads to small molecule inhibitors of the uPAR·uPA protein-protein interaction that block cancer cell invasion (Q35563311) (← links)
- Advances and challenges in immunotherapy for solid organ and hematopoietic stem cell transplantation (Q35586614) (← links)
- Investigational Notch and Hedgehog inhibitors--therapies for cardiovascular disease. (Q35603713) (← links)
- Targeting protein-protein interactions in hematologic malignancies: still a challenge or a great opportunity for future therapies? (Q35687836) (← links)
- Recent progress in targeting cancer (Q35740782) (← links)
- Ex vivo engineered immune organoids for controlled germinal center reactions (Q35812007) (← links)
- Insights into the Molecular Pathogenesis of Activated B-Cell-like Diffuse Large B-Cell Lymphoma and Its Therapeutic Implications (Q35818443) (← links)
- Small Molecule Inhibitors of Ca(2+)-S100B Reveal Two Protein Conformations. (Q35884035) (← links)
- K63-linked ubiquitination in kinase activation and cancer (Q35971438) (← links)
- Synthetic Lethal Screen Demonstrates That a JAK2 Inhibitor Suppresses a BCL6-dependent IL10RA/JAK2/STAT3 Pathway in High Grade B-cell Lymphoma (Q36042686) (← links)
- NAC1 is an actin-binding protein that is essential for effective cytokinesis in cancer cells. (Q36170245) (← links)
- JMJD1C is required for the survival of acute myeloid leukemia by functioning as a coactivator for key transcription factors (Q36199628) (← links)
- Integrin-specific hydrogels as adaptable tumor organoids for malignant B and T cells (Q36217436) (← links)
- Targeting Transcription Factors in Cancer (Q36347511) (← links)
- Bcl6 Sets a Threshold for Antiviral Signaling by Restraining IRF7 Transcriptional Program (Q36427920) (← links)
- SOX4 enables oncogenic survival signals in acute lymphoblastic leukemia (Q36512597) (← links)
- Aberrant expression of homeobox gene SIX1 in Hodgkin lymphoma (Q36545556) (← links)
- T Follicular Helper Cell Plasticity Shapes Pathogenic T Helper 2 Cell-Mediated Immunity to Inhaled House Dust Mite (Q36594029) (← links)
- The molecular biology of diffuse large B-cell lymphoma (Q36612630) (← links)
- Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin (Q36652029) (← links)
- BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition (Q36684951) (← links)
- Lineage-specific functions of Bcl-6 in immunity and inflammation are mediated by distinct biochemical mechanisms (Q36703936) (← links)
- Using biologic predictive factors to direct therapy of diffuse large B-cell lymphoma (Q36776444) (← links)
- B-cell lymphoma 6 promotes proliferation and survival of trophoblastic cells (Q36839342) (← links)
- PML-RARα co-operates with Sox4 in acute myeloid leukemia development in mice (Q36862383) (← links)